GW & Wade’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.96M | Sell |
2,229
-107
| -5% | -$94K | 0.06% | 175 |
|
|
2023
Q3 | $1.92M | Sell |
2,336
-30
| -1% | -$24.7K | 0.07% | 164 |
|
|
2023
Q2 | $1.7M | Buy |
2,366
+13
| +0.6% | +$9.34K | 0.06% | 175 |
|
|
2023
Q1 | $1.93M | Sell |
2,353
-61
| -3% | -$50.1K | 0.07% | 157 |
|
|
2022
Q4 | $1.74M | Buy |
2,414
+34
| +1% | +$24.5K | 0.07% | 157 |
|
|
2022
Q3 | $1.64M | Sell |
2,380
-68
| -3% | -$46.9K | 0.08% | 147 |
|
|
2022
Q2 | $1.45M | Buy |
2,448
+39
| +2% | +$23.1K | 0.07% | 162 |
|
|
2022
Q1 | $1.68M | Sell |
2,409
-282
| -10% | -$197K | 0.07% | 148 |
|
|
2021
Q4 | $1.7M | Buy |
2,691
+59
| +2% | +$37.3K | 0.07% | 150 |
|
|
2021
Q3 | $1.59M | Sell |
2,632
-19
| -0.7% | -$11.5K | 0.08% | 151 |
|
|
2021
Q2 | $1.48M | Buy |
2,651
+2
| +0.1% | +$1.12K | 0.07% | 151 |
|
|
2021
Q1 | $1.25M | Buy |
2,649
+1,217
| +85% | +$576K | 0.07% | 149 |
|
|
2020
Q4 | $692K | Buy |
1,432
+464
| +48% | +$224K | 0.04% | 169 |
|
|
2020
Q3 | $542K | Buy |
968
+83
| +9% | +$46.5K | 0.04% | 146 |
|
|
2020
Q2 | $552K | Buy |
+885
| New | +$552K | 0.05% | 142 |
|